Oncology care platform, Oncare, has raised ₹27 crore in a Series A round led by Sky Impact Capital to expand its cancer care network across India. The round also saw participation from Huddle Ventures, Lotus Herbal Group, SteerX and Tremis Capital.
The company said the funds will support expansion into metro markets and Tier-2 and Tier-3 cities. It will also invest in technology systems to streamline clinical operations and care coordination.
India’s oncology care market is projected to reach ₹43,000 crore by FY28, growing at a CAGR of about 14 per cent. Access to treatment remains uneven, with capacity concentrated in large hospitals.
Oncare said it operates a distributed oncology model. It integrates medical, surgical and radiation oncology within accredited hospitals. The platform maintains clinical governance, insurance integration and transparent pricing.
Deepak Kumar, Co-founder of Oncare, said, “A cancer diagnosis is overwhelming enough. Access to the right care should not make it harder”.
He added that the company’s goal with Oncare is to make high-quality treatment more accessible, transparent and patient-focused for families across India.
Aakash Sachdev, Founder of Sky Impact Capital, said, “India’s oncology challenge cannot be solved by infrastructure alone; it requires operating systems that scale quality, affordability and trust together”.
He said Oncare represents a next-generation approach and that Sky will apply its single-speciality healthcare model to support growth.
Oncare was founded in 2023 by Amar Sneh and Deepak Kumar. It operates four centres across Delhi NCR. The company said it has built a multi-centre platform within a short period.
The firm plans to build a national oncology network through a capex-light model. It aims to expand access to treatment closer to patients’ homes.
Sky Impact Capital invests in healthcare, education and consumer businesses. The firm said it partners with companies positioned for high growth, capable of delivering measurable impact.
(With inputs from BL intern Tejaswini S)
Published on February 23, 2026
